Condition
Intercritical Gout
Total Trials
3
Recruiting
0
Active
1
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 5/100
Termination Rate
0.0%
0 terminated out of 3 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
67%
2 trials in Phase 3/4
Results Transparency
100%
2 of 2 completed with results
Key Signals
2 with results100% success
Data Visualizations
Phase Distribution
2Total
P 3 (1)
P 4 (1)
Trial Status
Completed2
Active Not Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (3)
Showing 3 of 3 trials
NCT05522504Active Not Recruiting
Distribution of Immune Cells and Their Subtypes in Peripheral Blood of Gout
NCT00829829Phase 3CompletedPrimary
PREventative Study Against URate-lowering Drug-induced Gout Exacerbations 1
NCT01451645Phase 4CompletedPrimary
Efficacy and Safety of Colchicine for the Prevention of Gout Flares During the Initiation of Allopurinol
Showing all 3 trials